Innoviva: Funding, Investors & Team (Sep 2026)
Innoviva is committed to building long-lasting value and improving patient care, by partnering with companies that advance innovative therapies. Anchored by its respiratory assets, Innoviva blends a unique fusion of operational industry expertise and financial insight to create a solid foundation for capital returns—and carve a path towards a healthier world for patients.
Innoviva has raised $225M across 1 funding round on record, the most recent a Post-IPO Debt of $225M announced in Mar 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Innoviva Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Innoviva Funding Rounds
Innoviva Founders and Leadership Team
Contact details for the Innoviva team: 1 of 1 has an email address on file.
Start 14-day free trial →Innoviva Funding Compared to Other Biotechnology Startups
Innoviva's latest round of $225M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Innoviva in Biotechnology and Brisbane
Companies Similar to Innoviva
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Innoviva Funding FAQs
What does Innoviva do?
Innoviva is committed to building long-lasting value and improving patient care, by partnering with companies that advance innovative therapies. Anchored by its respiratory assets, Innoviva blends a unique fusion of operational industry expertise and financial insight to create a solid foundation for capital returns—and carve a path towards a healthier world for patients.
How much funding has Innoviva raised?
Innoviva has raised $225M across 1 round on record. The most recent is a Post-IPO Debt of $225M announced in Mar 2022.
When did Innoviva last raise funding?
Innoviva's most recent funding round on record is a Post-IPO Debt of $225M, announced in Mar 2022.
Who is the CEO of Innoviva?
Pavel Raifeld is listed as CEO at Innoviva.
Where is Innoviva headquartered?
Innoviva is based in Brisbane, California, United States.
How many employees does Innoviva have?
Innoviva is in the 11-50 employee band.
How does Innoviva's funding compare to other Biotechnology startups?
Innoviva's latest round of $225M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Innoviva Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Innoviva is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.